Your browser doesn't support javascript.
loading
Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma.
Wallace, Danielle S; Rowland, Chris; Hill, Brian T; Baran, Andrea M; Casulo, Carla; Reagan, Patrick M; Winter, Allison; Karmali, Reem; Winter, Jane N; Gordon, Leo I; Bui, Andrew; Sportelli, Peter; Miskin, Hari P; Weiss, Michael S; Friedberg, Jonathan W; Ma, Shuo; Barr, Paul M.
Afiliação
  • Wallace DS; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
  • Rowland C; TG Therapeutics, Inc, New York, NY, USA.
  • Hill BT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Baran AM; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA.
  • Casulo C; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
  • Reagan PM; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
  • Winter A; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Karmali R; Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.
  • Winter JN; Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.
  • Gordon LI; Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.
  • Bui A; TG Therapeutics, Inc, New York, NY, USA.
  • Sportelli P; TG Therapeutics, Inc, New York, NY, USA.
  • Miskin HP; TG Therapeutics, Inc, New York, NY, USA.
  • Weiss MS; TG Therapeutics, Inc, New York, NY, USA.
  • Friedberg JW; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
  • Ma S; Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.
  • Barr PM; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Leuk Lymphoma ; 64(9): 1579-1582, 2023 09.
Article em En | MEDLINE | ID: mdl-37341984
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article